TGFB1 and neoplasm: Alternatively, some studies have addressed mechanisms to increase NK cell infiltration at the tumor bed by neutralizing soluble factors that suppress NK cells function such as TGFβ, already entered in clinical trials also in combination with anti-PD1 (Dodagatta-Marri et al., 2019).